News from NYU Langone Health
They’ve Dropped the Weight. But What ѵ the Skin? (New York Times)
Paywalled* The (9/3) Obesity drugs like tirzepatide, Ozempic, Zepbound, and Wegovy are leading to increased cases of loose skin among users; Holly F. Lofton, MD, clinical associate professor, Departments of Surgery, Division of Bariatric Surgery, and Medicine, Division of General Internal Medicine and Clinical Innovation, explained that rapid weight loss can leave skin unable to rebound.
Physician Discusses Vaccination Recommendations; Banned Gel Polish Ingredients. (WNYW-TV New York)
(9/2) Rabia A. De Latour, MD, assistant professor, Department of Medicine, Division of Gastroenterology and Hepatology, discussed flu vaccination recommendations, emphasizing that while the optimal time for flu shots is before Halloween, the purpose is to protect vulnerable populations, and she mentioned that pooled data from clinical trials suggest high-dose flu vaccines may benefit the elderly, though conclusive evidence is pending; she also addressed concerns about a chemical in gel nail polish banned in Europe due to health risks, advising caution with cumulative chemical exposure.
Imperative Care Thrombectomy System Gets FDA Clearance For PE. (AuntMinnie)
(9/2) Imperative Care has secured FDA 510(k) clearance for its Symphony Thrombectomy System to treat pulmonary embolism, expanding its prior clearance for venous thrombosis treatment; this large-bore aspiration catheter system, featuring 16F and 24F catheters and the ProHelix Mechanical Assist tool, was validated through the SYMPHONY-PE study overseen by Vivian L. Bishay, MD, from Mount Sinai Health System, and Sripal Bangalore, MD, professor, Department of Medicine, the Leon H. Charney Division of Cardiology.
Also reporting is (9/2).
Transthyretin Amyloid Cardiomyopathy: What Is It And How Rare Is It Really? (MedPage Today)
(9/2) Transthyretin amyloid cardiomyopathy (ATTR-CM), once considered a rare disease, is increasingly diagnosed due to heightened awareness and improved diagnostic tools, with Jose A. Alvarez-Cardona, MD, assistant professor, Department of Medicine, the Leon H. Charney Division of Cardiology, saying, “There has been a notable shift toward earlier diagnosis of ATTR-CM due to increased awareness among providers and improved access to diagnostic tools, such as nuclear scintigraphy.”
Potassium Cardioprotective In People With An ICD. (Healio)
(8/29) The POTCAST trial, presented at the European Society of Cardiology Congress and published in The New England Journal of Medicine, revealed that increasing serum potassium levels in patients with an implantable cardioverter defibrillator (ICD) significantly reduced adverse cardiovascular outcomes, with a 24% risk reduction compared to standard care; Alexander Kushnir, MD, clinical assistant professor, Department of Medicine, the Leon H. Charney Division of Cardiology, in a Perspectives essay, said, “It’s a positive study, important because it offers a low-cost, easy-to-implement intervention for a very sick and expensive-to-treat patient population, with potential to reduce health care burden.”
Remote Atrial Fibrillation Screening With Wearable ECG Patch Confers ‘Modest’ Benefits. (Healio)
(8/29) The AMALFI trial, presented at the European Society of Cardiology Congress and published in JAMA, demonstrated that remote atrial fibrillation (AF) screening using a 14-day ECG patch modestly increased AF detection and anticoagulant treatment among older adults at risk for stroke, with AF diagnosed in 6.8% of the patch group versus 5.4% of the usual care group; Alexander Kushnir, MD, clinical assistant professor, Department of Medicine, the Leon H. Charney Division of Cardiology, in a Perspectives essay, emphasized the importance of targeted monitoring, noting that “Holter monitors are not benign, and many patients get severe rashes.”
78 Academic Medical Center CFOs To Know. (Becker's Hospital Review)
(9/2) Joseph J. Lhota, executive vice president and vice dean, CFO, and chief of staff, has been managing the financial operations, accounting, financial planning, analysis, budgets, revenue cycle operations, supply chain management, decision support, strategy, and value improvement since February 2024, leveraging over 40 years of managerial and policymaking experience to align resources with the institution’s commitment to clinical excellence and academic innovation, while also fostering partnerships with industry and community stakeholders.
These 2 Drinks Can Make You Go Gray And Bald – Plus The Nutrient That 5 Studies Say Can Help. (New York Post)
The (9/2) A scientific review analyzed by NYU Langone Health associates excessive consumption of sugary drinks and alcohol with increased hair loss and premature graying, affecting over 80% of men and nearly half of women in the US.
